Wichita Falls Times Record News
Here's what the new Panda Biotech hemp processing facility will actually do
Northwest Texas
•
Jul 26, 2021
Biotech
Latest Texas stories tagged “Biotech”.
Wichita Falls Times Record News
WTAW Radio College Station
Bryan ISD School Board Supports A Proposed $300 Million Dollar Expansion By FUJIFILM Diosynth Biotechnologies
Central Texas
•
Jul 21, 2021
Brenham Banner Press
Nanoscope Therapeutics Announces First Patient Dosed in Phase 2b clinical trial of Optogenetic Gene Monotherapy to Restore Vision in Patients with Retinitis Pigmentosa
Central Texas
•
Jul 19, 2021
Brenham Banner Press
Aeglea BioTherapeutics Appoints Jim Kastenmayer as General Counsel
Central Texas
•
Jul 15, 2021
Brenham Banner Press
Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency...
Central Texas
•
Jul 14, 2021
Rivard Report | San Antonio
Former San Antonio biotech company sells for $80 million
South Texas
•
Jul 14, 2021
Wichita Falls Times Record News
Panda Biotech closes on sale of old Delphi building
Northwest Texas
•
Jul 13, 2021
Brenham Banner Press
Toxicology IND Preclinical Research Services by Altogen Labs CRO
Central Texas
•
Jul 5, 2021
Waco Tribune Herald
The Latest: Indian-made vaccine works against all variants
Central Texas
•
Jul 3, 2021
KTTZ Radio Lubbock
Moderna Says Studies Show Its Vaccine Is Effective Against The Delta Variant
High Plains
•
Jun 30, 2021
WTAW Radio College Station
FUJIFILM Diosynth Biotechnologies Anuncia Una Expansin De $850 Millones En EE.UU. Y El Reino Unido
Central Texas
•
Jun 30, 2021
WTAW Radio College Station
FUJIFILM Diosynth Biotechnolgies Announces An $850 Million Dollar Expansion In The U.S. And The U.K.
Central Texas
•
Jun 30, 2021
CBS Local Dallas
Moderna: 'Encouraging' Data Shows Its COVID Vaccine Remains Protective Against Delta Variant
Metroplex
•
Jun 29, 2021
Brenham Banner Press
Aeglea BioTherapeutics Doses First Patient in a Phase 1/2 Clinical Trial of AGLE-177, a Potential First-in-Class Treatment for Homocystinuria
Central Texas
•
Jun 24, 2021
Waco Tribune Herald
CureVac founder withdraws candidacy for supervisory board
Central Texas
•
Jun 23, 2021
Texas Right To Life
New international guidelines allow anti-Life embryonic research; Texas has no rules.
Texas Politics
•
Jun 23, 2021
Brenham Banner Press
Nanoscope Therapeutics Announces FDA Approval of IND for Phase 2b clinical trial of Optogenetic Gene Monotherapy to Restore Vision in Patients with Retinitis Pigmentosa
Central Texas
•
Jun 23, 2021
Wichita Falls Times Record News
Panda Biotech president says company will purchase Delphi building this summer
Northwest Texas
•
Jun 15, 2021
KTBB Radio Tyler
Novavax COVID-19 vaccine: How it works and other things you should know
Upper East Texas
•
Jun 14, 2021
KTBB Radio Tyler
Novavax announces its COVID-19 vaccine is over 90% effective against symptomatic disease
Upper East Texas
•
Jun 14, 2021
KTBB Radio Tyler
New Alzheimer's drug is first of its kind to be FDA approved
Upper East Texas
•
Jun 7, 2021
Waco Tribune Herald
German biotech company MorphoSys buys US rival for $1.7B
Central Texas
•
Jun 2, 2021
Brenham Banner Press
Stealth BioTherapeutics Announces Additional Development Financing to Advance Elamipretide Clinical Trials
Central Texas
•
May 17, 2021